PwC: Pharma Supply Chains Need Overhaul
Pharmaceutical companies are facing increasing pressure to update their supply chains.
For some, it’s going to be an uphill battle.
A new report from PwC US concludes that many pharmaceutical supply chains have suffered from what amounts to benign neglect. Now, they are inefficient, under-utilized and ill-equipped to cope with new medicines, cost pressures and health reform expectations.
Essentially, the pharma supply chain needs to adopt a new consumer-oriented focus. As a result, PwC says we can expect the pharma supplier network to become: (more…)









